164 related articles for article (PubMed ID: 16429254)
1. Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis.
Neumann T; Oelzner P; Petrow PK; Thoss K; Hein G; Stein G; Bräuer R
Inflamm Res; 2006 Jan; 55(1):32-9. PubMed ID: 16429254
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Campagnuolo G; Bolon B; Feige U
Arthritis Rheum; 2002 Jul; 46(7):1926-36. PubMed ID: 12124878
[TBL] [Abstract][Full Text] [Related]
3. Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa.
Oelzner P; Bräuer R; Henzgen S; Thoss K; Wünsche B; Hersmann G; Abendroth K; Kinne RW
Clin Immunol; 1999 Jan; 90(1):79-88. PubMed ID: 9884355
[TBL] [Abstract][Full Text] [Related]
4. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Schett G; Middleton S; Bolon B; Stolina M; Brown H; Zhu L; Pretorius J; Zack DJ; Kostenuik P; Feige U
Arthritis Rheum; 2005 May; 52(5):1604-11. PubMed ID: 15880601
[TBL] [Abstract][Full Text] [Related]
5. Fcgamma receptors directly mediate cartilage, but not bone, destruction in murine antigen-induced arthritis: uncoupling of cartilage damage from bone erosion and joint inflammation.
van Lent PL; Grevers L; Lubberts E; de Vries TJ; Nabbe KC; Verbeek S; Oppers B; Sloetjes A; Blom AB; van den Berg WB
Arthritis Rheum; 2006 Dec; 54(12):3868-77. PubMed ID: 17133594
[TBL] [Abstract][Full Text] [Related]
6. High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton.
Oelzner P; Kunze A; Henzgen S; Thoss K; Hein G; Stein G; Bräuer R
Inflamm Res; 2000 Aug; 49(8):424-33. PubMed ID: 11028760
[TBL] [Abstract][Full Text] [Related]
7. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
Saidenberg-Kermanac'h N; Corrado A; Lemeiter D; deVernejoul MC; Boissier MC; Cohen-Solal ME
Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
[TBL] [Abstract][Full Text] [Related]
9. RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
Stolina M; Adamu S; Ominsky M; Dwyer D; Asuncion F; Geng Z; Middleton S; Brown H; Pretorius J; Schett G; Bolon B; Feige U; Zack D; Kostenuik PJ
J Bone Miner Res; 2005 Oct; 20(10):1756-65. PubMed ID: 16160733
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat.
Oelzner P; Fleissner-Richter S; Bräuer R; Hein G; Wolf G; Neumann T
Inflamm Res; 2010 Sep; 59(9):731-41. PubMed ID: 20306217
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.
Oelzner P; Petrow PK; Wolf G; Bräuer R
BMC Musculoskelet Disord; 2014 Oct; 15():345. PubMed ID: 25315028
[TBL] [Abstract][Full Text] [Related]
13. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis.
Roth A; Mollenhauer J; Wagner A; Fuhrmann R; Straub A; Venbrocks RA; Petrow P; Bräuer R; Schubert H; Ozegowski J; Peschel G; Müller PJ; Kinne RW
Arthritis Res Ther; 2005; 7(3):R677-86. PubMed ID: 15899053
[TBL] [Abstract][Full Text] [Related]
14. Antiinflammatory and chondroprotective effects of the aminobisphosphonate incadronate (YM175) in adjuvant induced arthritis.
Matsuo A; Shuto T; Hirata G; Satoh H; Matsumoto Y; Zhao H; Iwamoto Y
J Rheumatol; 2003 Jun; 30(6):1280-90. PubMed ID: 12784404
[TBL] [Abstract][Full Text] [Related]
15. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies.
Stolina M; Schett G; Dwyer D; Vonderfecht S; Middleton S; Duryea D; Pacheco E; Van G; Bolon B; Feige U; Zack D; Kostenuik P
Arthritis Res Ther; 2009; 11(6):R187. PubMed ID: 20003323
[TBL] [Abstract][Full Text] [Related]
16. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis.
Mould AW; Tonks ID; Cahill MM; Pettit AR; Thomas R; Hayward NK; Kay GF
Arthritis Rheum; 2003 Sep; 48(9):2660-9. PubMed ID: 13130487
[TBL] [Abstract][Full Text] [Related]
17. Bone protective effect of simvastatin in experimental arthritis.
Funk JL; Chen J; Downey KJ; Clark RA
J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
[TBL] [Abstract][Full Text] [Related]
18. NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis.
Francis MD; Hovancik K; Boyce RW
Int J Tissue React; 1989; 11(5):239-52. PubMed ID: 2517540
[TBL] [Abstract][Full Text] [Related]
19. FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats.
Niikura K; Nakajima S; Takano M; Yamazaki H
Bone; 2007 Apr; 40(4):888-94. PubMed ID: 17157574
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis.
van Lent PL; Grevers L; Blom AB; Sloetjes A; Mort JS; Vogl T; Nacken W; van den Berg WB; Roth J
Ann Rheum Dis; 2008 Dec; 67(12):1750-8. PubMed ID: 18055478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
